about
Effects of insulin on brain glucose metabolism in impaired glucose tolerance.Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipidsCirculating Docosahexaenoic Acid Associates with Insulin-Dependent Skeletal Muscle and Whole Body Glucose Uptake in Older Women Born from Normal Weight Mothers.Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist.A Partial Loss-of-Function Variant in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.Resistance training enhances insulin suppression of endogenous glucose production in elderly women.The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects.Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.Resistance training improves skeletal muscle insulin sensitivity in elderly offspring of overweight and obese mothers.Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow-up.Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic ProfilingAdipose tissue and skeletal muscle insulin-mediated glucose uptake in insulin resistance: role of blood flow and diabetesThe SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
P50
Q34527026-492D876A-9168-4431-B932-048974BD113EQ37150162-7BE9204E-10B0-492A-8673-BDC84863BF3FQ37673141-C07ADD2F-1AAF-4424-A926-41F47E236AAAQ38629996-C6AC17DE-B2E6-4498-B6C4-01B1081E5E78Q43491389-2DC57DD6-56A2-48C7-A0F3-0936403FD007Q46079580-5BF15ED6-A8A7-41FF-A166-C12ACDA5A898Q46718590-EB447E2D-18FC-4440-A058-236FDD3B9E14Q47590663-4DB06E58-6F0C-4C65-B9A0-F75489861069Q48266739-01E436AA-79E4-4209-BDFF-F405E6E6D428Q51357902-5A2A76F0-4FEA-451C-9F29-0D7F21C8BB0FQ51763477-BAB699D7-DA54-4AA9-9E53-5FF3E6A0F2AFQ52986596-7BFFD2D3-EB69-48D0-9E94-D077B13DA180Q52990141-663B9A8E-1093-4E1F-8458-277CBF3A9DC1Q64921303-2310DA8A-2ECA-4E4E-97AF-AC5608C6A41EQ90783131-1B9E7C18-6E69-437C-84F6-E9A6468092EEQ91617454-BACA6943-9C5E-4110-8185-572D3741CAC0Q92458814-6BB45413-4A7C-42DD-ACBA-09BA49174D58
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Miikka-Juhani Honka
@ast
Miikka-Juhani Honka
@en
Miikka-Juhani Honka
@es
Miikka-Juhani Honka
@nl
Miikka-Juhani Honka
@sl
type
label
Miikka-Juhani Honka
@ast
Miikka-Juhani Honka
@en
Miikka-Juhani Honka
@es
Miikka-Juhani Honka
@nl
Miikka-Juhani Honka
@sl
prefLabel
Miikka-Juhani Honka
@ast
Miikka-Juhani Honka
@en
Miikka-Juhani Honka
@es
Miikka-Juhani Honka
@nl
Miikka-Juhani Honka
@sl
P106
P31
P496
0000-0001-9875-5863